To explore the mechanistic interplay between mitochondrial dysfunction and glioma progression, we focused on mitochondrial carrier homolog 2 (MTCH2), a critical regulator of mitochondrial metabolism and related cell death (Robinson et al. 2012; Veresov and Davidovskii 2014). The gene discussed is MTCH2; the disease is glioma.